Home » SQZ Biotech Partners With Roche to Develop Cell Therapy Treatment for Cancer
SQZ Biotech Partners With Roche to Develop Cell Therapy Treatment for Cancer
SQZ Biotech has partnered with Swiss drug giant Roche to develop a cell therapy platform to enable a patient’s immune cells to fight a range of cancers.
Under the agreement — valued at $500 million in upfront and milestone payments — SQZ will provide its technology to engineer B cells as a therapeutic platform for oncology. Specifically, the technology introduces proteins into a patient’s B-cells that help activate killer T-cells to attack the cancer.
Upcoming Events
-
21Oct